N@N

Market Maker Surveillance Report. IBCP, ADES, NYMX, ITMN, BASI, BLTI, Winning Stocks With Lowest Price Friction For Friday, De

^{Published on 2010-12-17 19:00:43, Last Modified on 2010-12-22 19:47:16 - WOPRAI}
 

December 17, 2010 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 2571 companies with "abnormal" market making, 2768 companies with positive Friction Factors and 2348 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. INDEPENDENT BANK CORP - MICH (NASDAQ:IBCP), ADA-ES INC (NASDAQ:ADES), NYMOX PHARMACEUTICAL CORP (NASDAQ:NYMX), INTERMUNE INC (NASDAQ:ITMN), BIOANALYTICAL SYSTEMS INC (NASDAQ:BASI), BIOLASE TECHNOLOGY INC (NASDAQ:BLTI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     IBCP       $0.380       37.62%       721,770         55.08%       588,457         44.91%       133,313         3,508   
     ADES       $2.250       29.22%       273,730         61.87%       159,337         36.01%       114,393         508     
     NYMX       $2.330       52.24%       1,157,496       48.65%       1,095,873       46.06%       61,623          264     
     ITMN       $20.700      145.06%      17,261,770      50.17%       16,663,424      48.43%       598,346         289     
     BASI       $0.870       48.34%       117,497         61.43%       68,967          36.06%       48,530          558     
     BLTI       $0.560       41.80%       152,072         66.46%       73,475          32.11%       78,597          1,404   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows BLTI with a dollar gain Friday of $0.56000 and a Friction Factor of 1,404 shares. That means that it only took 1,404 more shares of buying than selling to move BLTI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

INDEPENDENT BANK CORP - MICH (NASDAQ:IBCP) - Independent Bank Corporation operates as a holding company for the Independent Bank that provides various commercial banking services in Michigan. The company offers various deposit products, including non-interest bearing demand deposits, time deposits, checking and savings accounts, and NOW accounts. It also provides commercial lending, direct and indirect consumer financing, and safe deposit box services. The company, through its other subsidiaries, offers mortgage lending services, payment plans used by consumers to purchase vehicle service contracts, and title insurance services, as well as provides investment and insurance services. As of June 25, 2010, it operated approximately 100 offices across Michigans Lower Peninsula. The company was founded in 1864 and is based in Ionia, Michigan.

ADA-ES INC (NASDAQ:ADES) - ADA-ES, Inc. provides environmental technologies and specialty chemicals to the coal-burning utility industry in the United States. It engages in the development and marketing of refined coal technology for the control of nitrogen oxides and mercury; sale of equipment, field testing, and services related to mercury emission control for coal-fired boilers used in electric generation; research and development of carbon dioxide capture technology; and sale of flue gas conditioning equipment and chemicals, as well as other chemicals and technologies for coal-fired boilers. The company has a joint venture agreement with Energy Capital Partners I, LP and its affiliated funds for the construction and operation of a new Greenfield facility in Louisiana for the manufacture of activated carbon for mercury control applications. It also offers consulting services that assist utilities in planning and implementing strategies to meet new government emission standards requiring reductions in sulfur dioxide, nitrogen oxide, particulates, and mercury. The company was founded in 1996 and is based in Littleton, Colorado.

NYMOX PHARMACEUTICAL CORP (NASDAQ:NYMX) - Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs and diagnostic devices in Canada, the United States, and Europe. The companys products include AlzheimAlert, a urinary test that aids physicians in the diagnosis of Alzheimers disease; and NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. Its products under development comprise NX-1207, which is in Phase III clinical trials for the treatment of benign prostatic hyperplasia; and NX-1207, which is ready for human clinical trials for the treatment of hepatocellular carcinoma and localized prostate cancer. The companys products in the preclinical stage comprise NXC-4720, an antibacterial agent for the treatment of E. coli O157:H7 bacterial contamination in hamburger meat and other food and drink products, and for the treatment of urinary tract and other bacterial infections in humans; NXB-4221 for the treatment of difficult chronic and persistent urinary tract infections; NXB-5886 for the treatment of streptococcal infection; and NXT-1021 for the treatment of staphylococcal infection. It is also developing therapeutics for Alzheimers disease; drugs for the treatment of Alzheimers disease that target spherons; and therapeutic products for oncological indications, as well as holds various diagnostic markers and technologies, including a patented platform for point-of-care testing. Nymox Pharmaceutical was founded in 1989 and is based in St. Laurent, Canada.

INTERMUNE INC (NASDAQ:ITMN) - InterMune, Inc., a biotech company, focuses on developing and commercializing therapies in pulmonology and hepatology primarily in the United States and Europe. The company primarily offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic granulomatous disease. Its pulmonology product portfolio includes lead product candidate, pirfenidone, a phase III product being developed for the treatment of patients with idiopathic pulmonary fibrosis; and a research program focused on small molecules for pulmonary diseases. The companys hepatology portfolio comprises the HCV protease inhibitor RG7227, a phase IIb chronic hepatitis C program and an early stage research program evaluating a new target in hepatology. It has license and collaboration agreements with Hoffmann-LaRoche Inc. and F. Hoffmann-LaRoche Ltd.; Genentech, Inc.; Boehringer Ingelheim International GmbH; Connetics Corporation; and Novartis Corporation. The company was founded in 1998 and is headquartered in Brisbane, California.

BIOANALYTICAL SYSTEMS INC (NASDAQ:BASI) - Bioanalytical Systems, Inc. provides contract development services and research equipment to pharmaceutical, medical research, and biotechnology companies and institutions worldwide. The company operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment provides various services, including screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; and liquid chromatography and electrochemistry instruments platforms. This segment offers three principal product lines: analytical products, in vivo sampling products, and vetronics products. The analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. The in vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments. These are used by pharmaceutical researchers to dose animals and collect biological samples from the animals. The vetronics products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram) and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

BIOLASE TECHNOLOGY INC (NASDAQ:BLTI) - BIOLASE Technology, Inc., a medical technology company, develops, manufactures, and markets lasers and related products and services focused on technologies for applications and procedures in dentistry and medicine. Its principal products are dental laser systems that allow general dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. The company offers two categories of laser system products comprising Waterlase family of products and Diode family of products. The Waterlase systems use a combination of water and laser to perform dental procedures for cutting soft and hard tissue plus bone. Its Waterlase systems include Waterlase MD and Waterlase C100 All-Tissue Dental Laser systems. The Diode systems use a semiconductor diode laser to perform soft tissue, hygiene, and cosmetic procedures, including teeth whitening, as well as pain management therapy. Its Diode systems consist of the ezlase, iLase, and Diolase 10 systems. The company also provides related accessories and disposable products for its laser systems, which include disposable laser tips, flexible fibers, hand pieces, and tooth whitening gel kits. BIOLASE Technology, Inc. sells its products through direct sales force and a network of independent distributors in the United States and internationally. The company was formerly known as Societe Endo Technic, SA and changed its name to BIOLASE Technology, Inc. in 1994. BIOLASE Technology, Inc. was founded in 1984 and is headquartered in Irvine, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net